|
|
Volumn 29, Issue 5, 2012, Pages 3597-3598
|
|
A severe delayed infusion reaction induced by trastuzumab: A life-threatening condition
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADRENALIN;
ANTIHISTAMINIC AGENT;
CETUXIMAB;
CHLORPHENIRAMINE;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
EPIRUBICIN;
FLUOROURACIL;
INSULIN;
METHYLPREDNISOLONE;
PARACETAMOL;
RITUXIMAB;
TRASTUZUMAB;
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
ADULT;
AEROSOL;
BREAST CANCER;
BREAST CARCINOMA;
CANCER ADJUVANT THERAPY;
CANCER SURGERY;
CASE REPORT;
DIABETIC OBESITY;
DRUG HYPERSENSITIVITY;
DRUG INFUSION;
DRUG WITHDRAWAL;
DYSPNEA;
EMERGENCY WARD;
FEMALE;
FOLLOW UP;
HOSPITAL DISCHARGE;
HUMAN;
HYPERTENSION;
INSULIN DEPENDENT DIABETES MELLITUS;
LETTER;
LOW DRUG DOSE;
MEDICAL HISTORY;
MULTIPLE CYCLE TREATMENT;
PRIORITY JOURNAL;
SIDE EFFECT;
SINUS TACHYCARDIA;
SWEATING;
SYSTOLIC HYPERTENSION;
TREATMENT DURATION;
TREMOR;
BREAST TUMOR;
MIDDLE AGED;
OBESITY;
PAGET NIPPLE DISEASE;
PATHOPHYSIOLOGY;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CARCINOMA, DUCTAL, BREAST;
DIABETES MELLITUS, TYPE 1;
DRUG HYPERSENSITIVITY;
FEMALE;
HUMANS;
HYPERTENSION;
MIDDLE AGED;
OBESITY;
|
|
EID: 84880307505
PISSN: 13570560
EISSN: 1559131X
Source Type: Journal
DOI: 10.1007/s12032-012-0298-5 Document Type: Letter |
|
Times cited : (6)
|
|
References (3)
|
